Proteomic analysis and verification of protein expression after upregulation of human CD99 in Hodgkin lymphoma cell line L428
10.3760/cma.j.issn.0253-2727.2019.06.008
- VernacularTitle: 过表达CD99后霍奇金淋巴瘤细胞株L428细胞蛋白表达变化的蛋白质组学分析及验证
- Author:
Xiangling LIN
1
;
Qingcan SUN
;
Yin LU
;
Xiqun HAN
;
Tong ZHAO
;
Xinhua ZHOU
Author Information
1. Department of Pathology, Southern Medical University, Guangdong Province Key Laboratory of Molecular Tumor Pathology, Guangzhou 510515, China
- Publication Type:Journal Article
- Keywords:
CD99;
Hodgkin Lymphoma;
L428 cell;
Mass spectrometry analysis;
Hodgkin/Reed-Sternberg cell
- From:
Chinese Journal of Hematology
2019;40(6):490-496
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the proteins expression difference after upregulation of human CD99 in Hodgkin Lymphoma cell line, L428 cell, and verify the function of differential proteins.
Methods:The differential proteins were detected by two-dimensional fluorescence difference gel electrophoresis and mass spectrometry analysis, cluster analysis was done by GOfact.
Results:There were 38 proteins screened out, of which 21 proteins were positively associated with CD99, while 17 proteins were negative. Among the 38 proteins, 32 proteins participated in biological process, and 35 proteins were involved in the composition and construction. And 28 proteins participated in multifaceted biological activities including antioxidation, protein binding, catalytic activity, regulation of enzyme, signal transduction, molecular structure, regulation of translation and ion transport.
Conclusions:The changes of the differential proteins, correlated with cytoskeleton, cell differentiation, signal pathway and regulating gene expression, are closely relevant to the translation between Hodgkin/Reed-Sternberg and B lymphocyte cell.
